Abiraterone acetate + prednisone

Abiraterone acetate + prednisone has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest story, Nov 2, 2026: “Men faced high fracture risk after prostate cancer drugs”.

Intervention

1 paper studies itUpdated

PubChemPubChemChEBIChEBI

See all 1 papers on abiraterone acetate + prednisone

  • Humans1

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months
Journal of the National Cancer Institute

Men faced high fracture risk after prostate cancer drugs

Three-year fracture risk exceeded 25% without a recent fracture and 50% with one; it remained above 44% among men with prior fractures using bone-health medicines.Three-year fracture risk exceeded 25% without a recent fracture and 50% with one; it remained above 44% among men with prior fractures using bone-health medicines.

Cohort · 10,463 peopleBone fracture